
|Articles|August 20, 2014
The Medical Innovation Threat
Advertisement
An invasive species has been introduced into the U.S. health innovation ecosystem, with a growing danger of permanent damage to the development of specialty drugs. The relentless assault on the price of Sovaldi is becoming a threat to the 30-year political balance that has energized the biomedical revolution.
Source: The Wall Street Journal
Read the full story:
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Top 5 Most-Read Multiple Sclerosis Articles of 2025
2
2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA
3
Long-Term Trial Shows Durable Efficacy, QOL Gains With Nirogacestat in Desmoid Tumors
4
Top 5 Trending FDA Approvals of 2025
5







































